Hepatitis B Virus Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Hepatitis B Virus stocks.

Hepatitis B Virus Stocks Recent News

Date Stock Title
May 30 BMY Bristol-Myers Squibb's Options: A Look at What the Big Money is Thinking
May 30 BMY Bristol Myers' Breyanzi gains additional indication for mantle cell lymphoma
May 29 VIR Vir Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
May 29 BMY Prothena (PRTA), Bristol Myers Tie Up for Second Neuro Candidate
May 29 BMY Bristol-Myers gets EU approval for Opdivo for bladder cancer
May 29 BMY BMS secures another EC approval for Opdivo combination
May 29 BMY BMS stakes $80m on Prothena’s neurodegenerative candidate
May 29 VIR Vir Biotechnology names Mark Eisner as chief medical officer
May 29 VIR Vir Biotechnology Appoints Mark Eisner, M.D., M.P.H. as Chief Medical Officer
May 29 ABUS Arbutus to Participate in Jefferies Global Healthcare Conference
May 29 BMY Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma
May 29 NNVC A First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including RSV, COVID, Influenzas and More
May 28 IONS Ionis: Tough Run For Share Price Belies Multiple Reasons For Optimism
May 28 BMY ASPIRE: Our Commitment To Address Health Inequities in Low- and Middle-Income Countries
May 28 NTLA Cathie Wood's Ark Innovation ETF Sees Sharp Decline Among Top Holdings — Here Are 10-Largest Losers Within ARKF
May 28 IONS Ionis to hold donidalorsen Phase 3 data webcast
May 25 BMY Viking, CRISPR, Intellia among potential M&A targets: Wells Fargo
May 25 NTLA ARK Invest's Cathie Wood Snags These 3 Bargains — Are They Right for Your Portfolio?
May 24 HOOK HOOKIPA stock falls 20% in wake of Phase 1/2 study results
May 24 IONS The Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar Therapeutics
Hepatitis B Virus

Hepatitis B virus (HBV), is a partially double-stranded DNA virus, a species of the genus Orthohepadnavirus and a member of the Hepadnaviridae family of viruses. This virus causes the disease hepatitis B.

Browse All Tags